Abstract
Aim:
To investigate the antiproliferative effect of triptolide on B-NHL cell line Raji cells, to study its effect on lymph node metastasis in patients with non-Hodgkin's lymphoma (NHL) in vitro, and to explore the underlying mechanism regulating SDF-1/CXCR4 axis.
Methods:
The effects of triptolide on the growth of Raji cells were studied by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium (MTT) assay. The effects of triptolide on SDF-1 mRNA expression in lymph node stromal cells from patients with NHL were determined by reverse transcriptase-polymerase chain reaction (RT-PCR). The effects of triptolide on CXCR4 expression on lymphoma cells freshly isolated from the lymph nodes of these patients were studied by flow cytometric analysis. Chemotaxis assays were performed to observe the effects of triptolide on migration of primary lymphoma cells towards recombinant human SDF-1α (rhSDF-1α) or cultured lymph node stromal cells in vitro.
Results:
Triptolide inhibited the proliferation of B-NHL cell line Raji cells in a dose- and time-dependent manner with a 24-h IC50 value of 43.06 nmol/L and a 36-h IC50 value of 25.08 nmol/L. The expression of SDF-1α mRNA in lymph node stromal cells obtained from patients with NHL was decreased after treatment by triptolide at concentrations of 25 and 50 nmol/L for 24 h. Flow cytometry analysis showed that the CXCR4 expression on primary lymphoma cells were downregulated gradually in a dose-dependent manner following triptolide treatment. Chemotaxis assays revealed that the migration of freshly isolated lymphoma cells towards either rhSDF-1 or cultured lymph node stromal cells was markedly inhibited by the addition of triptolide in vitro, and the inhibition was dose-dependent.
Conclusion:
Triptolide can inhibit the proliferation of B-NHL cell line Raji cells. Moreover, triptolide is able to inhibit the migration of lymphoma cells via lymph nodes in vitro. The potential antitumor mechanisms of triptolide are related to the antiproliferative effect and the blockage of SDF-1/CXCR4 axis.
Similar content being viewed by others
Article PDF
References
Chen BJ . Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F. Leuk Lymphoma 2001; 42: 253–65.
Yang S, Chen J, Guo Z, Xu XM, Wang L, Pei XF, et al. Triptolide inhibits the growth and metastasis of solid tumors. Mol Cancer Ther 2003; 2: 65–72.
Cyster JG . Chemokines and cell migration in secondary lymphoid organs. Science 1999; 286: 2098–102.
Muller G, Hopken UE, Lipp M . Systemic immunoregulatory and pathogenic functions of homeostatic chemokine receptors. J Leukoc Biol 2002; 72: 1–8.
Kucia M, Reca R, Miekus K, Wanzeck J, Wojakowski W, Janowska-Wieczorek A, et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 2005; 23: 879–94.
Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 50–6.
Phillips RJ, Burdick MD, Lutz M, Belperio JA, Keane MP, Strieter RM . The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med 2003; 167: 1676–86.
Sun YX, Wang J, Shelburne CE, Lopatin DE, Chinnaiyan AM, Rubin MA, et al. Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J Cell Biochem 2003; 89: 462–73.
Zhou Y, Larsen PH, Hao C, Yong VW . CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 2002; 277: 49481–7.
Barbero S, Bonavia R, Bajetto A, Porcile C, Pirani P, Ravetti JL, et al. Stromal cell derived factor 1α stimulates human glioblas-toma cell growth through the activation of both extracellular signal-regulated kinase 1/2 and Akt. Cancer Res 2003; 63: 1969–74.
Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U . Williams Hematology. 4th ed. New York (NY): McGraw-Hill Pro-fession-al; 2000. p 1049–57.
Bertolini F, Dell'Agnola C, Mancuso P, Rabascio C, Burlini A, Monestiroli S, et al. CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma. Cancer Res 2002; 62: 3106–12.
Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–92.
Yinjun L, Jie J, Yungui W . Triptolide inhibits transcription factor NF-kappaB and induces apoptosis of multiple myeloma cells. Leuk Res 2005; 29: 99–105.
Lou YJ, Jin J . Triptolide down-regulates bcr-abl expression and induces apoptosis in chronic myelogenous leukemia cells. Leuk Lymphoma 2004; 45: 373–6.
Chang WT, Kang JJ, Lee KY, Wei K, Anderson E, Gotmare S, et al. Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the p53 pathway. J Biol Chem 2001; 276: 2221–7.
Zhou YX, Huang YL, Xu QN, Ye M, Sun CF, Zhou D . Several monomes from Tripterygium wilfordii inhibit proliferation of glioma cells in vitro. Ai Zheng 2002; 21: 1106–8.
Sanchez-Madrid F, del Pozo MA . Leukocyte polarization in cell migration and immune reactions. EMBO J 1999; 18: 501–11.
Trentin L, Cabrelle A, Facco M, Carollo D, Miorin M, Tosoni A, et al. Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas. Blood 2004; 104: 502–8.
Bradstock KF, Makrynikola V, Bianchi A, Shen W, Hewson J, Gottlieb DJ . Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers. Leukemia 2000; 14: 882–8.
Weng AP, Shahsafaei A, Dorfman DM . CXCR4/CD184 immu-noreactivity in T-cell non-Hodgkin lymphomas with an overall Tlr Th2+ immunophenotype. Am J Clin Pathol 2003; 119: 424–30.
Arai J, Yasukawa M, Yakushijin Y, Miyazaki T, Fujita S . Stromal cells in lymph nodes attract B-lymphoma cells via production of stromal cell-derived factor-1. Eur J Haematol 2000; 64: 323–32.
Liu F, Cui GH, Zhang C, Wang Y, Chen Y . Effects of triptolide on the expression of vascular endothelial growth factor (VEGF) in cultured Raji cells. Chin Hosp Pharm J 2004; 24: 413–5.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the National Natural Science Foundation of China (No 30472267).
Rights and permissions
About this article
Cite this article
Zhang, C., Cui, Gh., Liu, F. et al. Inhibitory effect of triptolide on lymph node metastasis in patients with non-Hodgkin lymphoma by regulating SDF-1/CXCR4 axis in vitro. Acta Pharmacol Sin 27, 1438–1446 (2006). https://doi.org/10.1111/j.1745-7254.2006.00415.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2006.00415.x
Keywords
This article is cited by
-
Dynamic Interactions Between Cancer Stem Cells and Their Stromal Partners
Current Pathobiology Reports (2014)
-
Herbal compound triptolide synergistically enhanced antitumor activity of amino-terminal fragment of urokinase
Molecular Cancer (2013)
-
Triptolide induces cell-cycle arrest and apoptosis of human multiple myeloma cells in vitro via altering expression of histone demethylase LSD1 and JMJD2B
Acta Pharmacologica Sinica (2012)
-
MRx102, a triptolide derivative, has potent antileukemic activity in vitro and in a murine model of AML
Leukemia (2012)
-
Anti-cancer natural products isolated from chinese medicinal herbs
Chinese Medicine (2011)